← Evidence map

TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment.

Gerhardt Attard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

82 papers cite itlatest 60 shown

2018
…
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30028657